Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes

Neurosci Lett. 2010 Jan 22;469(2):234-6. doi: 10.1016/j.neulet.2009.12.002. Epub 2009 Dec 4.

Abstract

Progranulin has recently attracted attention due to the discovery of mutations in its encoding gene (GRN) in several cases of frontotemporal lobar degeneration, but also for a possible role in inflammatory processes. In adult central nervous system, GRN mRNA is expressed in forebrain, olfactory bulbs and spinal cord. Progranulin cerebrospinal fluid (CSF) levels were evaluated in 55 patients with multiple sclerosis (MS) as well as in 35 subjects with non-inflammatory neurological diseases (NIND), 7 individuals with other inflammatory neurological disease (OIND) and 8 controls (CON), matched for ethnic background, gender and age. No statistically significant differences were found in patients compared with either NIND, OIND or CON (P>0.05), even stratifying according to disease subtype or gender. A positive correlation between progranulin CSF levels and age was observed in patients (rho=0.29, P=0.03). According to these data, progranulin does not likely play a major role in the pathogenesis of MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age Factors
  • Brain Diseases / cerebrospinal fluid
  • Ethnicity
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / cerebrospinal fluid*
  • Male
  • Middle Aged
  • Multiple Sclerosis, Chronic Progressive / cerebrospinal fluid*
  • Multiple Sclerosis, Relapsing-Remitting / cerebrospinal fluid*
  • Progranulins
  • Sex Factors

Substances

  • GRN protein, human
  • Intercellular Signaling Peptides and Proteins
  • Progranulins